Financhill
Sell
27

EBS Quote, Financials, Valuation and Earnings

Last price:
$8.14
Seasonality move :
1.23%
Day range:
$7.70 - $8.35
52-week range:
$1.42 - $15.10
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.39x
P/B ratio:
0.86x
Volume:
2.5M
Avg. volume:
1.3M
1-year change:
263.23%
Market cap:
$438.9M
Revenue:
$1B
EPS (TTM):
-$4.10

Earnings Data

Next earnings date for EBS
Mar 06
2025
Most recent earnings per share
$2.06
Beat by $1.92
(Nov 6/2024)
Consensus Estimate
$0.14
(Nov 6/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

EBS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/06/2025 Q4 $259M -- -- -$0.64 --
11/06/2024 Q3 $297.5M $283.8M $2.06 $0.14 $1.92
08/06/2024 Q2 $190M $248.1M -$5.38 -- --
05/01/2024 Q1 $220.3M $292.4M $0.17 -$0.83 $1.00
03/06/2024 Q4 $274M $269.9M -$0.95 -$0.32 -$0.63
11/02/2023 Q3 -- -- -$5.08 -$0.62 -$4.46
08/08/2023 Q2 -- -- -$5.15 -$0.63 -$4.53
05/09/2023 Q1 -- -- -$3.65 -$1.34 -$2.31
02/27/2023 Q4 -- -- -$1.76 -$0.06 -$1.70
11/08/2022 Q3 -- -- -$1.52 -$0.13 -$1.39
08/01/2022 Q2 -- -- -$1.13 $0.40 -$1.53
04/28/2022 Q1 -- -- -$0.07 $0.13 -$0.20
02/24/2022 Q4 -- -- $3.50 $4.42 -$0.92
11/04/2021 Q3 -- -- -$0.61 $2.28 -$2.89
07/29/2021 Q2 -- -- $0.09 $1.56 -$1.47
04/29/2021 Q1 -- -- $1.28 $1.17 $0.11
02/18/2021 Q4 -- -- $3.44 $3.41 $0.03
11/05/2020 Q3 -- -- $0.73 $2.15 -$1.42
07/30/2020 Q2 -- -- $1.73 $0.66 $1.08
04/30/2020 Q1 -- -- -$0.24 -$0.01 -$0.23
02/20/2020 Q4 -- -- $0.89 $1.73 -$0.84
11/06/2019 Q3 -- -- $0.83 $0.90 -$0.07
08/01/2019 Q2 -- -- -- $0.18 --
05/02/2019 Q1 -- -- -- $0.18 --
02/21/2019 Q4 -- -- -- $0.65 --
11/01/2018 Q3 -- -- -- $0.61 --
08/02/2018 Q2 -- -- -- -- --
05/03/2018 Q1 -- -- -- -- --
02/22/2018 Q4 -- -- -- -- --
11/02/2017 Q3 -- -- -- -- --
08/03/2017 Q2 -- -- -- -- --
05/04/2017 Q1 -- -- -- -- --
02/23/2017 Q4 -- -- -- -- --
11/07/2016 Q3 -- -- -- -- --
08/04/2016 Q2 -- -- -- -- --
05/05/2016 Q1 -- -- -- -- --
02/25/2016 Q4 -- -- -- -- --
11/05/2015 Q3 -- -- -- -- --
08/06/2015 Q2 -- -- -- -- --
05/07/2015 Q1 -- -- -- -- --
03/05/2015 Q4 -- -- -- -- --

Emergent BioSolutions Earnings Questions

  • How Much did Emergent BioSolutions Generate in Revenue Last Quarter?

    Emergent BioSolutions reported $283.8M worth of top line sales in its most recent quarter.

  • Did Emergent BioSolutions Beat Earnings Last Quarter?

    Emergent BioSolutions announced earnings per share of $2.06 which represents a beat of analyst forecast a $0.14 per share.

  • Is Emergent BioSolutions Profitable?

    Emergent BioSolutions reported $161.2M that represents $2.90 per share over the last quarter.

  • What is the Analyst Consensus for Emergent BioSolutions EPS Next Year?

    Emergent BioSolutions's earnings are forecast to decrease from -$14.85 per share to -$4.87 per share next year representing a decrease of -93.27%.

  • When is Emergent BioSolutions's Earnings Date?

    Emergent BioSolutions's next earnings date is March 6, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 3.65% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 4.9% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 4.4% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock